1 year return (CAGR)
-10.56%
ChemoMetec A/S Exchange (CO, DKK)
CHEMM.CO
580.00
-5.00 (-0.85%)
HealthcareMedical Devices
Loading...
3 year return (CAGR)
21.57%
5 year return (CAGR)
-11.89%
10 year return (CAGR)
30.63%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
9.95B
Price/Sales
9.89
Ent value
9.80B
Price/Book
13.72
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
105.96%
Trailing P/E
25.64
PEG
-
Forward P/E
35.59
EPS growth
17.97%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 593.00 |
| Daily high | 607.00 |
| Daily low | 580.00 |
| Daily Volume | 81K |
| All-time high | 1128.00 |
| 1y analyst estimate | 635.00 |
| Beta | 1.39 |
| EPS (TTM) | 22.32 |
| Dividend per share | 0.00 |
| Ex-div date | 10 Oct 2025 |
| Next earnings date | 5 May 2026 |
Downside potential
Loading...
Downside potential data
| CHEMM.CO | S&P500 | |
| Current price drop from All-time high | -48.58% | -1.06% |
| Highest price drop | -88.30% | -56.47% |
| Date of highest drop | 28 Dec 2012 | 9 Mar 2009 |
| Avg drop from high | -46.03% | -10.67% |
| Avg time to new high | 44 days | 12 days |
| Max time to new high | 1941 days | 1805 days |
News
ANNOUNCEMENT NO. 319 8 October 2026 The Annual General Meeting of ChemoMetec A/S was held on 8 October 2026 at 17:30 at Nordsjællands KonferenceCenter. At the Annual General Meeting, the Board of Dire...
October 8, 2026
ANNOUNCEMENT NO. 3175 October 2026 ChemoMetec maintained its positive momentum in the first quarter of the 2026/27 financial year, supported by higher-than-expected demand for our instruments, with th...
October 5, 2026
ANNOUNCEMENT NO. 3162 October 2026 ChemoMetec A/S has completed the share buyback programme announced in company announcement no. 309 dated 15 May 2026. The programme provided for the repurchase of up...
October 2, 2026
ChemoMetec AS (STU:CHY) posted record DKK511 million revenue with a 55% EBITDA margin, but management's conservative FY26/27 outlook and rising CapEx keep investors guessing.
September 19, 2026
16 September 2026ANNOUNCEMENT NO. 315 Major shareholder announcement - BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed Chemo...
September 16, 2026
ANNOUNCEMENT NO. 312 10 September 2026 ChemoMetec today approved the annual report for 2025/26, including the guidance for 2026/27, which is considered inside information. For the financial year 2026/...
September 10, 2026
ANNOUNCEMENT NO. 309 15 May 2026 Initiation of buy-back programme The Board of Directors of ChemoMetec A/S has decided to buy back own shares based on the authorisation granted at the Annual General M...
May 15, 2026
ChemoMetec has seen a sharp share price swing over recent years, and the question now is whether the current price can be explained by the cash it is expected to generate. With a Discounted Cash Flow ...
October 9, 2026
ANNOUNCEMENT NO. 31310 September 2026 Annual Report 2025/26 (1 July 2025 - 30 June 2026) Positioning ChemoMetec for future growth Despite changes and uncertainty affecting ChemoMetec's markets, revenu...
September 10, 2026
ANNOUNCEMENT NO. 311 After entering a Letter of Intent with Roche Diagnostics in February 2026, aiming to pursue a collaboration with the goal of creating synergies between the parties’ solutions in t...
August 10, 2026